GlassScriptPhysician profile
Adam Matynowski
NPI 1770225211
$1,749.66
in general payments reported to CMS, 2019-2025
9 companies · $961 in 2025
The $961 reported for 2025 was more than what 87% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $153 · 2023: $186 · 2024: $449 · 2025: $961.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,596.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calyxo, INC. | $528.39 | 2025 | Cvac Aspiration System |
| Boston Scientific Corporation | $340.97 | 2023-2024 | Lithovue |
| Ferring Pharmaceuticals INC. | $206.44 | 2024-2025 | Adstiladrin |
| Medtronic, INC. | $153.30 | 2022 | |
| Photocure INC | $134.40 | 2024 | Cysview |
| Janssen Biotech, INC. | $124.74 | 2025 | Carvykti, Rybrevant |
| Dendreon Pharmaceuticals LLC | $122.76 | 2025 | Provenge |
| Myriad Genetic Laboratories, INC. | $108.30 | 2025 | Prolaris |
| Urogen Pharma, INC. | $30.36 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Matynowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.